🇺🇸 FDA
Patent

US 8404818

Monoclonal antibodies against orthopoxviruses

granted A61KA61K2039/505A61K2039/545

Quick answer

US patent 8404818 (Monoclonal antibodies against orthopoxviruses) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Mar 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/505, A61K2039/545, A61K39/00, A61P